SYNAGIS
Solution for injection, 50mg/0.5ml
RxActive license
Active substance (INN)
palivizumab
Pharmaceutical form
Pharmaceutical formSolution for injection
Strength50mg/0.5ml
PackagingUkupno 1 bočica staklena sa 0.5ml rastvora za injekciju u kartonskoj kutiji
ManufacturerAbbVie S.r.l., Italy
Therapeutic groupAnti-infectives for systemic use (J06BD01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateMarch 17, 2026
Source: CInMED register